Trial Profile
Ceftaroline fosamil in patients with complicated/refractory MRSA infections
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 09 Jan 2014
Price :
$35
*
At a glance
- Drugs Ceftaroline fosamil (Primary)
- Indications Abscess; Bacteraemia; Embolism; Endocarditis; Methicillin-resistant Staphylococcus aureus infections; Osteomyelitis
- Focus Therapeutic Use
- 09 Jan 2014 New trial record